The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.7M data for 1.2M Compounds and 9.0K Targets. Of those, 1,244K data for 572K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

32 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.EBI
University of Tennessee Health Science Center
Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer.EBI
University of Tennessee Health Science Center
Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.EBI
University of Tennessee Health Science Center
Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).EBI
University of Tennessee Health Science Center
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.EBI
University of Tennessee Health Science Center
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.EBI
University of Tennessee Health Science Center
Structural studies of pterin-based inhibitors of dihydropteroate synthase.EBI
University of Tennessee Health Science Center
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.EBI
University of Tennessee Health Science Center
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.EBI
University of Tennessee Health Science Center
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.EBI
University of Tennessee Health Science Center
Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.EBI
University of Tennessee Health Science Center
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.EBI
University of Tennessee Health Science Center
Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.EBI
University of Tennessee Health Science Center
Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel alpha-ketoamides incorporating polar residues at the P1'-position.EBI
University of Tennessee Health Science Center
Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.EBI
University of Tennessee Health Science Center
Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.EBI
University of Tennessee Health Science Center
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.EBI
University of Tennessee Health Science Center
Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties.EBI
University of Tennessee Health Science Center
Synthesis, docking, and biological studies of phenanthrene ?-diketo acids as novel HIV-1 integrase inhibitors.EBI
University of Tennessee Health Science Center
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.EBI
University of Tennessee Health Science Center
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.EBI
University of Tennessee Health Science Center
Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.EBI
University of Tennessee Health Science Center
Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.BDB
University of Tennessee Health Science Center
Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.BDB
University of Tennessee Health Science Center
Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.BDB
University of Tennessee Health Science Center